经脐单孔腹腔镜技术治疗妇科附件良性疾病疗效分析

Effect analysis of laparoendoscopic single site surgery for benign gynecological adnexal benign disease

目的探讨单孔腹腔镜技术治疗妇科附件良性疾病的有效性。方法笔者所在医院妇产科2018年6月—2019年3月收治的83例附件良性疾病患者,随机分为单孔腹腔镜手术组42例(试验组)和传统多孔腹腔镜手术组41例(对照组),比较两组患者手术时间、术中出血量、术后排气时间、住院时间、术后疼痛情况及患者满意度等临床效果。结果两组患者手术均获成功,无1例中转开腹。两组比较,手术时间、术中出血量、术后排气时间、住院时间均无统计学差异(P>0.05);两组术后疼痛评分及满意度调查对比,试验组患者术后疼痛感轻微,满意度高,与对照组相比,差异有统计学意义(P<0.05)。术后病理证实均为良性病变,与术前诊断相符。83例均随访1~3个月,无切口感染、愈合不良,无腹腔内出血、切口疝等术后并发症。结论经脐单孔腹腔镜技术治疗妇科附件良性疾病安全、效果可靠,术后疼痛轻且美容效果突出,不增加手术时间及出血量,患者接受度更高,具有极大的优势,值得推广应用。

Objective To investigate the effect of laparoendoscopic single-site surgery(LESS)in the treatment of benign gynecological adnexal disease.Methods The 83 cases of benign adnexal disease from Jun.2018 to Mar.2019 admitted in authors'hospital were divided into trial group(42 cases,received LESS)and control group(41 cases,conventional laparoscopic surgery)randomly.The clinical outcomes of operation time,intraoperative bleeding volume,postoperative exhaustion time,hospitalization time,postoperative pain and patient's satisfaction degree were compared between the two groups.Results All the surgeries of the two groups were successful,with no conversion to the open surgery.There was no statistical difference between the two groups regarding the operation time,the intraoperative blood loss,the postoperative exhaustion time and hospital stay(P>0.05).The comparative investigation of the two groups on pain score and postoperative satisfaction confirmed that the patients under LESS had less painful feeling and higher satisfaction(P<0.05).All the postoperative pathologies confirmed benign lesions which were consistent with the preoperative diagnosis.All the 83 cases were all followed-up for 1-3 months and no case of umbilical incisional infection,poor healing,intraperitoneal bleeding,umbilical hernia and other postoperative complications happened.Conclusion LESS for benign gynecological adnexal disease is safe,reliable,and less painful.Meanwhile,it also has a good cosmetic efficacy,operation time is no more and bleeding volume.Owing to above advantages,LESS has a greater acceptance to patients and is worth promoting the application.